|

Advanced Glycation Products and Vascular Complications in Type 1 Diabetes

RECRUITINGSponsored by CHU de Reims
Actively Recruiting
SponsorCHU de Reims
Started2023-01-25
Est. completion2024-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06458088

Summary

DIABAGE (Diabetes Advanced Glycation End products) study was conducted between 2015 and 2017. It included 196 type 1 diabetic patients with more than 10 years of diabetes. It revealed a significant association between the occurrence of vascular complications and tissular Advanced Glycation End products (AGEs) as well as with some circulating AGEs. This protocol is a continuation of that initial research.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Inclusion in initial DIABAGE study.
* Follow-up at Reims hospital.

Exclusion Criteria:

\- Refusal to participate.

Conditions2

DiabetesType1diabetes

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.